Role of Injection Depo Medoroxy Progesterone Acetate in the Management of Abnormal Uterine Bleeding in Norplant User

Authors

  • Mahfuz Ara Begum Associate Professor (Obstetrics & Gynae), Comilla Medical College, Comilla
  • Begum Aminun Nahar Senior Consultant, M Abdur Rahim Medical College Hospital, Dinajpur
  • Monowara Sultana Counselor, Family Planning Model Clinic SSMC & Mitford Hospital, Dhaka
  • Md Amjad Ali Consultant, Department of Orthopedic, Bangladesh Modernized Hospital, Mohammadpur, Dhaka, Ex Consultant NITOR, Dhaka

DOI:

https://doi.org/10.3329/icmj.v7i1-2.53967

Keywords:

Injection Depo Medoroxy progesterone acetate, abnormal uiterine bleeding, Norplant etc.

Abstract

Background & objective: This prospective study was undertaken to determine the role of Depomedroxy progesterone acetate (DMPA) in the management of abnormal uterine bleeding associated with norplant use.

Methods: The study was carried out in the Department of Family Planning Model Clinic of Sir Salimullah Medical College and Mitford Hospital, Dhaka between June, 2003 to December, 2005. A total 54 clients were consecutively selected, based on predefined enrolment criteria.

Results: Over two-thirds (70.6%) of the patients were multipara (2-3 live births), 22% primipara and the rest 7.4% grand-multipara (4 or more live births). Among 54 cases, 45(84%) responded to treatment. Of the 9 (16%) cases who failed to respond to DMPA treatment, 4 cases were given 2nd dose of DMPA. Three cases dropped out after failing the 1st dose and 2 cases refused to receive 2nd dose and their norplant was removed on request. Abnormal per vaginal (P/V) bleeding began from the 1st month of insertion of Norplant with 15 (27.7%) cases in the 1st month, 7(12%) cases between 2nd to 5th months, 16(28%) cases between 6-12 months, 11(20%) between 13-24 months and 5 (9.3%) cases between 25-36 months.

Conclusion: The study showed that DMPA is a simple and effective modality of treatment for women with abnormal or irregular uterine bleeding associated with norplant implant use. With increased compliance from clients’ perspective, it could be a good option for treatment of women with abnormal or irregular uterine bleeding caused by norplant implant.

Ibrahim Card Med J 2017; 7 (1&2): 80-83

Downloads

Download data is not yet available.
Abstract
71
PDF
88

Downloads

Published

2019-03-04

How to Cite

Begum, M. A., Nahar, B. A., Sultana, M., & Ali, M. A. (2019). Role of Injection Depo Medoroxy Progesterone Acetate in the Management of Abnormal Uterine Bleeding in Norplant User. Ibrahim Cardiac Medical Journal, 7(1-2), 80–83. https://doi.org/10.3329/icmj.v7i1-2.53967

Issue

Section

Original Article